Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    savita thakur thakur
    savita thakur thakur
      • Home
      • savita thakur thakur

      Articles By : savita thakur thakur

      Medtronic questioned by US senator on Bone Graft Injury data

      Medtronic questioned by US senator on Bone Graft Injury data

      savita thakur thakur14 April 2016 2:25 PM IST
      U.S. Senator Al Franken asked federal regulators and Medtronic Inc for detailed information about injuries associated with the company's bone graft...
      US prescription drug spending to hit $400 billion a year by 2020: IMS

      US prescription drug spending to hit $400 billion a year by 2020: IMS

      savita thakur thakur14 April 2016 2:23 PM IST
      U.S. annual spending on prescription medicines will increase 22 percent over the next five years, climbing as high as $400 billion in 2020, according...
      BDR Pharma and Lee Pharma end battle to copy drugs amid patent debate

      BDR Pharma and Lee Pharma end battle to copy drugs amid patent debate

      savita thakur thakur13 April 2016 3:54 PM IST
      Mumbai : Two drugmakers said they had given up a battle to copy drugs developed by Bristol Myers Squibb and AstraZeneca, blaming a lack of government...
      Eli Lilly to widen its drug portfolio

      Eli Lilly to widen its drug portfolio

      savita thakur thakur13 April 2016 3:39 PM IST
      Chennai : Global pharma major Eli Lilly will widen its therapeutic drug portfolio to include pain management and others while it would launch one...
      16 year old Indian American student invents low cost hearing aid

      16 year old Indian American student invents low cost hearing aid

      savita thakur thakur13 April 2016 3:39 PM IST
      Houston : A 16-year-old Indian-American boy has created a low-cost hearing aid costing USD 60 to help those who cannot afford expensive devices.Mukund...
      Pharma may report good growth for Q4 of last fiscal: Report

      Pharma may report good growth for Q4 of last fiscal: Report

      savita thakur thakur13 April 2016 3:38 PM IST
      Mumbai : The pharma sector is expected to report good growth for the fourth quarter of 2015-16 despite regulatory concerns raised by USFDA and the...
      Stryker Acquires SafeWire Product Portfolio for Use in Minimally-Invasive Spine Procedures

      Stryker Acquires SafeWire Product Portfolio for Use in Minimally-Invasive Spine Procedures

      savita thakur thakur13 April 2016 9:39 AM IST
      Allendale : Stryker’s Spine division announced the acquisition of the SafeWire product portfolio, including the Y-Wire guidewire and Tiger Jamshidi...
      FDA approves drug for tough to treat type of leukemia

      FDA approves drug for tough to treat type of leukemia

      savita thakur thakur12 April 2016 12:28 PM IST
      Trenton : The U.S. Food and Drug Administration on Monday approved a new type of drug that targets a subset of leukemia patients with a genetic...
      Lupin to market Novartis inhaler under Loftair brand name

      Lupin to market Novartis inhaler under Loftair brand name

      savita thakur thakur12 April 2016 12:26 PM IST
      New Delhi : Drug major Lupin and Novartis Healthcare have inked a co-marketing agreement under which Lupin will market Novartis' inhaler, used to...
      Orchid Pharma gets EIR report from USFDA on inspection closure

      Orchid Pharma gets EIR report from USFDA on inspection closure

      savita thakur thakur12 April 2016 12:25 PM IST
      New Delhi : Orchid Pharma has received the Establishment inspection report (EIR) from the US health regulator based on the successful inspection...
      App spots respiratory illness as you cough into smartphone

      App spots respiratory illness as you cough into smartphone

      savita thakur thakur11 April 2016 6:33 PM IST
      Sydney : An Australia-based digital health solution provider has developed an app that can diagnose respiratory diseases like pneumonia, croup and...
      FDA approves Pfizers biosimilar for inflammatory diseases

      FDA approves Pfizers biosimilar for inflammatory diseases

      savita thakur thakur10 April 2016 9:09 AM IST
      Pfizer Inc's drug for multiple inflammatory diseases was approved in the United States, making it the second biosimilar to be approved by the U.S....
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok